Vivanza Biosciences Financial Statements

Vivanza Biosciences Key Financial Ratios

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth 49.40 85.40 -- --
Op profit growth (157) (292) 416 --
EBIT growth (62) (325) 345 --
Net profit growth (200) (166) 416 --
Profitability ratios (%)        
OPM (3.50) 9.35 (9) --
EBIT margin 2.38 9.37 (7.70) --
Net profit margin (2.10) 3.19 (9) --
RoCE 5.38 12.70 (11) --
RoNW (1.50) 1.41 (4.40) --
RoA (1.20) 1.09 (3.20) --
Per share ratios ()        
EPS -- 0.51 -- --
Dividend per share -- -- -- --
Cash EPS (0.50) 0.51 (0.80) (3.20)
Book value per share 7.70 9.33 8.83 1.60
Valuation ratios        
P/E -- 137 -- --
P/CEPS -- 136 (244) (24)
P/B -- 7.51 21.50 48.30
EV/EBIDTA -- 53.50 (193) (32)
Payout (%)        
Dividend payout -- -- -- --
Tax payout -- (12) -- --
Liquidity ratios        
Debtor days 220 215 133 --
Inventory days 61.60 116 95.10 --
Creditor days (238) (231) (126) --
Leverage ratios        
Interest coverage (0.50) (1.60) 6.17 1,071
Net debt / equity 1.03 1.15 0.92 15.70
Net debt / op. profit (9.30) 7.12 (10) (7.70)
Cost breakup ()        
Material costs (97) (86) (88) --
Employee costs (3.10) (2.10) (12) --
Other costs (3.90) (2.70) (8.70) --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Revenue 9.62 6.44 3.47 --
yoy growth (%) 49.40 85.40 -- --
Raw materials (9.30) (5.50) (3.10) --
As % of sales 96.60 85.90 88.30 --
Employee costs (0.30) (0.10) (0.40) --
As % of sales 3.10 2.13 12 --
Other costs (0.40) (0.20) (0.30) (0.10)
As % of sales 3.86 2.66 8.75 --
Operating profit (0.30) 0.60 (0.30) (0.10)
OPM (3.50) 9.35 (9) --
Depreciation -- -- -- --
Interest expense (0.40) (0.40) -- --
Other income 0.57 -- 0.05 --
Profit before tax (0.20) 0.23 (0.30) (0.10)
Taxes -- -- -- --
Tax rate -- (12) -- --
Minorities and other -- -- -- --
Adj. profit (0.20) 0.21 (0.30) (0.10)
Exceptional items -- -- -- --
Net profit (0.20) 0.21 (0.30) (0.10)
yoy growth (%) (200) (166) 416 --
NPM (2.10) 3.19 (9) --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Profit before tax (0.20) 0.23 (0.30) (0.10)
Depreciation -- -- -- --
Tax paid -- -- -- --
Working capital 0.32 0.63 (0.60) --
Other operating items -- -- -- --
Operating cashflow 0.11 0.84 (0.90) --
Capital expenditure 2.50 -- -- --
Free cash flow 2.61 0.84 (0.90) --
Equity raised 2.94 (0.90) (0.40) --
Investments -- -- -- --
Debt financing/disposal 0.89 2.22 2.22 --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 6.44 2.11 0.85 --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 4 4 4 4
Preference capital -- -- -- --
Reserves (0.90) (0.70) (0.30) (0.50)
Net worth 3.08 3.29 3.73 3.53
Minority interest
Debt 0.39 1.48 1.32 0.90
Deferred tax liabilities (net) -- -- -- --
Total liabilities 3.47 4.77 5.05 4.43
Fixed assets 2.31 2.31 2.31 2.31
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) -- -- -- --
Net working capital 3.93 5.46 5.69 4.43
Inventories 0.97 2 2.28 1.81
Inventory Days 36.80 -- 129 190
Sundry debtors 6.54 5.70 5.07 2.53
Debtor days 248 -- 287 266
Other current assets 5.31 4.09 3.45 2.83
Sundry creditors (8.10) (5.70) (4.80) (2.60)
Creditor days 309 -- 274 269
Other current liabilities (0.70) (0.70) (0.30) (0.20)
Cash (2.80) (3) (3) (2.30)
Total assets 3.46 4.77 5.03 4.41
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2020 Sep-2020 Jun-2020 Mar-2020 Dec-2019
Gross Sales 4.08 2.22 0.69 5.97 3.12
Excise Duty -- -- -- -- --
Net Sales 4.08 2.22 0.69 5.97 3.12
Other Operating Income -- -- -- -- --
Other Income 0.04 0.36 -- 0.53 0.04
Total Income 4.12 2.57 0.69 6.50 3.17
Total Expenditure ** 3.84 2.12 0.85 5.93 3.22
PBIDT 0.28 0.45 (0.20) 0.57 (0.10)
Interest 0.11 0.24 0.01 0.08 0.11
PBDT 0.17 0.21 (0.20) 0.49 (0.20)
Depreciation -- -- -- -- --
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- --
Deferred Tax -- -- -- -- --
Reported Profit After Tax 0.17 0.21 (0.20) 0.49 (0.20)
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 0.17 0.21 (0.20) 0.49 (0.20)
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 0.17 0.21 (0.20) 0.49 (0.20)
EPS (Unit Curr.) 0.41 0.52 (0.40) 1.22 (0.40)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 4 4 4 4 4
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 6.86 20.30 (23) 9.55 (1.90)
PBDTM(%) 4.17 9.46 (25) 8.21 (5.40)
PATM(%) 4.17 9.46 (25) 8.21 (5.40)
Open ZERO Brokerage Demat Account